These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6926917)

  • 1. Clinical observations with Naprosyn.
    Tamási I; Gomez R; Szegedi G
    Ther Hung; 1982; 30(4):184-8. PubMed ID: 6926917
    [No Abstract]   [Full Text] [Related]  

  • 2. [Naprosyn in the treatment of rheumatoid arthritis. Report on a 5-month trial].
    Trnavský K; Boŝmanský K; Zbojanová M
    Fysiatr Revmatol Vestn; 1981 Apr; 59(2):97-101. PubMed ID: 7016699
    [No Abstract]   [Full Text] [Related]  

  • 3. [Naprosyn in the treatment of rheumatoid arthritis. Report on 5 months' therapy].
    Trnavsky K; Bosmansky K; Zbojanová M
    Reumatizam; 1982; 29(2):48-51. PubMed ID: 7051213
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of once and twice daily naproxen in rheumatoid arthritis.
    Mowat AM; Mowat AG; Jones CW; Engler C
    Br J Clin Pract; 1984 Mar; 38(3):95-8. PubMed ID: 6370285
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chronopharmacological and pharmacokinetic evaluation of the therapeutic effect of naproxen in rheumatoid arthritis].
    Mamistova AI
    Ter Arkh; 1987; 59(4):132-5. PubMed ID: 3589989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-rheumatic efficacy of naproxen.
    Philip J; Joseph PP; Das KV
    J Assoc Physicians India; 1982 Sep; 30(9):593-6. PubMed ID: 6764215
    [No Abstract]   [Full Text] [Related]  

  • 7. [Observations on the therapeutic efficacy and tolerability of a new drug with anti-inflammatory and analgesic action in patients with arthropathies of various types].
    Coltorti M
    Minerva Med; 1967 Apr; 58(32):1424-9. PubMed ID: 6029505
    [No Abstract]   [Full Text] [Related]  

  • 8. A clinical study of naproxen in rheumatoid arthritis.
    Remans J; Berghs H
    J Belge Rhumatol Med Phys; 1976; 31 Suppl():25-30. PubMed ID: 1032141
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical evaluation of the preparation Naprosyn manufactured by Krka].
    Gburek Z; Libera I; Socha A
    Reumatologia; 1982; 20(1-2):69-73. PubMed ID: 6761814
    [No Abstract]   [Full Text] [Related]  

  • 10. Indoprofen compared with naproxen and placebo in rheumatoid arthritis.
    Berry H; Fernandes L; Clarke AK; Hamilton EB; Davies J; Dixon AS
    Eur J Rheumatol Inflamm; 1981; 4(1):87-92. PubMed ID: 7042367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, cross-over study of naproxen sodium and soluble aspirin in rheumatoid arthritis.
    Clarke AK; Macleod M; Steinberg VL; Wenley WG
    Br J Clin Pract; 1981 Apr; 35(4):143-6. PubMed ID: 7028063
    [No Abstract]   [Full Text] [Related]  

  • 12. Naproxen (Naprosyn) and ketoprofen (Orudis).
    Drug Ther Bull; 1974 Mar; 12(7):25-7. PubMed ID: 4616814
    [No Abstract]   [Full Text] [Related]  

  • 13. [Naproxen in the treatment of inflammatory and degenerative diseases of the locomotor system].
    Szulc EJ; Rykowski T
    Wiad Lek; 1978 Jan; 31(2):97-100. PubMed ID: 654274
    [No Abstract]   [Full Text] [Related]  

  • 14. Cognitive dysfunction associated with naproxen and ibuprofen in the elderly.
    Goodwin JS; Regan M
    Arthritis Rheum; 1982 Aug; 25(8):1013-5. PubMed ID: 7115443
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experimentation with indomethacin suppositories].
    Trota E
    Clin Ter; 1967 Dec; 43(5):475-9. PubMed ID: 5617694
    [No Abstract]   [Full Text] [Related]  

  • 16. Crossover comparison of benoxaprofen and naproxen in rheumatoid arthritis.
    Atkinson MH; Brown TA; Robinson HS; Willkens RF
    J Rheumatol Suppl; 1980; 6():109-15. PubMed ID: 6993666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Trials of Hydrosarpan 711 in rheumatology].
    Chervonaz D
    Bord Med; 1972 Jan; 5(2):183-6. PubMed ID: 5012203
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of degenerative joint diseases of a rheumatic nature. Effectiveness of naproxen at a daily dosage of 500 mg].
    Biehl G
    Fortschr Med; 1980 Oct; 98(40):1568-70. PubMed ID: 7461554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of salhumin baths on rheumatic and traumatic joint diseases].
    Mund-Hoym WD
    Med Welt; 1981 Sep; 32(37):1378-81. PubMed ID: 6457958
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of valdecoxib and naproxen in the treatment of rheumatoid arthritis symptoms.
    Williams GW; Kivitz AJ; Brown MT; Verburg KM
    Clin Ther; 2006 Feb; 28(2):204-21. PubMed ID: 16678642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.